Armed Forces Institute of Regenerative Medicine


METRC is partnering with the Armed Forces Institute for Regenerative Medicine (AFIRM) to ensure timely identification of advanced treatment options that are appropriate for clinical evaluation.


The Armed Forces Institute of Regenerative Medicine (AFIRM) is a multi-institutional, interdisciplinary network working to develop advanced treatment options for our severely wounded servicemen and women. The AFIRM is managed and funded

through the US Army Medical Research and Materiel Command (MRMC); with additional funding from the US Navy, Office of Naval Research; the US Air Force, Office of the Surgeon General; the National Institutes of Health; the Veterans Administration; and local public and private matching funding.

The AFIRM is made up of two civilian research consortia working with the US Army Institute of Surgical Research (USAISR). One consortium is led by Wake Forest University Baptist Medical Center and the McGowan Institute for Regenerative Medicine in Pittsburgh and the other is led by Rutgers (State University of New Jersey) and the Cleveland Clinic. Each of these civilian consortia is itself a multi-institutional network.

The AFIRM is designed to speed the delivery of regenerative medicine therapies to treat our most severely-injured servicemembers from around the world, but in particular those coming from our theaters of operation in Iraq and Afghanistan. The AFIRM has five major research programs:

  • Limb Repair and Salvage
  • Craniofacial Reconstruction
  • Burn Repair
  • Scarless Wound Repair
  • Compartment Syndrome Repair